Brief: Chinook Therapeutics As Consideration For Rights Granted To Sanreno Under License Agreement

Chinook Therapeutics

30/11/2021 21:32

Nov 30 (Reuters) - Chinook Therapeutics Inc  KDNY.O :
    * CHINOOK THERAPEUTICS - AS CONSIDERATION FOR RIGHTS GRANTED
TO
SANRENO UNDER LICENSE AGREEMENT, CO GOT 50% OWNERSHIP IN
OUTSTANDING SHARES OF SANRENO
    * CHINOOK THERAPEUTICS -  AN INVESTOR SYNDICATE, EXISTING
CHINOOK
INVESTORS INVESTED $40 MILLION IN EXCHANGE FOR REMAINING 50%
OWNERSHIP OF SANRENO

Further company coverage:  KDNY.O